cytidine monophosphate has been researched along with cytarabine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (35.71) | 18.7374 |
| 1990's | 16 (57.14) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorr, RT; Iyengar, BS; Remers, WA | 1 |
| Buchheit, DJ; Hong, CI; Kirisits, AJ; Nechaev, A; West, CR | 2 |
| Kim, SH; Rosowsky, A; Ross, J; Wick, MM | 1 |
| Abraham, TW; Kalman, TI; McIntee, EJ; Wagner, CR | 1 |
| Zaborowska, D; Zuk, J | 1 |
| Deguchi, K; Kageyama, S; Komada, F; Minami, N; Morita, K; Nishikawa, M; Shirakawa, S; Uemura, Y | 1 |
| Higashigawa, M; Hori, H; Kawasaki, H; Ohkubo, T; Sakurai, M; Yoshizumi, T | 1 |
| Chen, SR; Cuddy, DP; Ross, DD | 1 |
| Suga, T; Takayama, H; Watanabe, T; Yamada, J; Yoshida, Y | 1 |
| Arakawa, M; Ekimoto, H; Ishii, T; Kusama, K; Nagahata, T; Shibasaki, C; Takahashi, K; Uchida, T | 1 |
| Kodama, K; Kuninaka, A; Morozumi, M; Saitoh, K; Saneyoshi, M; Yoshino, H | 1 |
| Haynes, RH; Kunz, BA; McIntosh, EM | 1 |
| Rooze, M | 1 |
| Campbell, J; Mayhew, E; Rustum, YM; Szoka, F | 1 |
| Myers-Robfogel, MW; Spataro, AC | 1 |
| Harrington, C; Perrino, FW | 1 |
| Arie, Y; Hirai, M; Kikukawa, M; Kodo, H; Kumakawa, T; Mizutani, R; Mori, M; Murai, Y; Nakamura, N; Tsutsumi, H | 1 |
| Braess, J; Hiddemann, W; Kaufmann, C; Ramsauer, B; Schleyer, E; Schüssler, M; Unterhalt, M; Wilde, S | 1 |
| Niitsu, N; Shikoshi, K; Takada, M; Umeda, M | 1 |
| Tsukagoshi, S | 1 |
| Ito, T; Konishi, H; Maesako, Y; Mori, S; Ueda, Y; Yagiri, Y | 1 |
| Braess, J; Freund, M; Hanauske, A; Heil, G; Hiddemann, W; Kaufmann, C; Kern, W; Schleyer, E; Schüssler, M | 1 |
| Harvey, S; Mazur, DJ; Perrino, FW; Ward, H | 1 |
| Berger, U; Hehlmann, R; Hochhaus, A; Kuhn, C; Reiter, A | 1 |
| Leen, R; van Gennip, AH; van Kuilenburg, AB; Verschuur, AC; Voûte, PA | 1 |
| Capasso, JM; Hirschberg, CB | 2 |
2 review(s) available for cytidine monophosphate and cytarabine
| Article | Year |
|---|---|
[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues].
Topics: Animals; Antimetabolites, Antineoplastic; Arabinonucleotides; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Cytidine Monophosphate; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Neoplasm Transplantation | 1997 |
AraC-based pharmacotherapy of chronic myeloid leukaemia.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Clinical Trials as Topic; Cytarabine; Cytidine Monophosphate; Drug Administration Schedule; Guidelines as Topic; Humans; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Survival Analysis | 2001 |
3 trial(s) available for cytidine monophosphate and cytarabine
| Article | Year |
|---|---|
Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative.
Topics: Administration, Oral; Antineoplastic Agents; Arabinofuranosyluracil; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Dose-Response Relationship, Drug; Half-Life; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Statistics, Nonparametric | 1995 |
[A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Time Factors | 1998 |
Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
Topics: Acute Disease; Administration, Oral; Adult; Antineoplastic Agents; Arabinonucleotides; Biological Availability; Cytarabine; Cytidine Monophosphate; Diarrhea; Dose-Response Relationship, Drug; Half-Life; Humans; Infusions, Intravenous; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Prodrugs; Regression Analysis | 1998 |
23 other study(ies) available for cytidine monophosphate and cytarabine
| Article | Year |
|---|---|
Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry; Leukemia L1210; Mice; Mitomycin; Mitomycins; Nucleotides | 1991 |
Nucleoside conjugates. 6. Synthesis and comparison of antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids and selected lipophilic alcohols.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Agents; Arabinonucleotides; Cytidine Deaminase; Esters; Female; Humans; Leukemia L1210; Male; Mice | 1985 |
Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cytarabine; Drug Resistance; Esters; Hydrolysis; Leukemia L1210; Melanoma; Mice; Neoplasms, Experimental | 1982 |
Synthesis and biological activity of aromatic amino acid phosphoramidates of 5-fluoro-2'-deoxyuridine and 1-beta-arabinofuranosylcytosine: evidence of phosphoramidase activity.
Topics: Animals; Cell Division; Cell Line; Cytarabine; Floxuridine; Humans; Magnetic Resonance Spectroscopy; Mice; Organophosphorus Compounds; Phosphoric Monoester Hydrolases; Thymidylate Synthase; Tumor Cells, Cultured | 1996 |
The effect of DNA replication on mutation of the Saccharomyces cerevisiae CDC8 gene.
Topics: Arabinonucleotides; Buffers; Caffeine; Cycloheximide; Cytarabine; Cytidine Monophosphate; DNA Replication; DNA, Fungal; Genes, Fungal; Hydroxyurea; Mutation; Phenotype; Phosphates; Saccharomyces cerevisiae; Ultraviolet Rays | 1990 |
[A case of complete remission from acute unclassified leukemia achieved by using a prodrug of ara C, stearyl-ara-CMP (YNK01)].
Topics: Acute Disease; Administration, Oral; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukemia; Middle Aged; Prodrugs; Remission Induction | 1990 |
Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Chromatography, High Pressure Liquid; Cytarabine; Cytidine Monophosphate; Deoxyribonucleotides; Leukemia P388; Male; Mice | 1990 |
Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
Topics: Arabinonucleotides; Cytarabine; Cytidine Monophosphate; DNA Replication; DNA, Neoplasm; Humans; Hydrogen-Ion Concentration; Kinetics; Leukemia, Promyelocytic, Acute; Thymidine; Tumor Cells, Cultured | 1990 |
Participation of the peroxisomal beta-oxidation system in the chain-shortening of PCA16, a metabolite of the cytosine arabinoside prodrug, YNKO1, in rat liver.
Topics: Animals; Arabinonucleotides; Cells, Cultured; Clofibrate; Coenzyme A Ligases; Cytarabine; Cytidine Monophosphate; Cytosine Nucleotides; Hydrogen Peroxide; Ketone Bodies; Liver; Microbodies; Mitochondria, Liver; Palmitates; Prodrugs; Rats; Rats, Inbred Strains; Repressor Proteins; Saccharomyces cerevisiae Proteins | 1990 |
[Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Cytosine Nucleotides; Drug Administration Schedule; Drug Screening Assays, Antitumor; Female; Injections, Intraperitoneal; Injections, Intravenous; Leukemia L1210; Male; Mice; Neoplasms, Experimental; Tumor Cells, Cultured | 1990 |
Antitumor activity and pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate: an orally active derivative of 1-beta-D-arabinofuranosylcytosine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Cytosine Nucleotides; Drug Administration Schedule; Leukemia L1210; Metabolic Clearance Rate; Mice; Solubility; Structure-Activity Relationship | 1989 |
Inhibition of DNA replication in Saccharomyces cerevisiae by araCMP.
Topics: Arabinonucleotides; Biological Transport; Cell Division; Chromatography, High Pressure Liquid; Cytarabine; Cytidine Monophosphate; Cytosine Nucleotides; DNA Replication; DNA, Fungal; Mitosis; Recombination, Genetic; Saccharomyces cerevisiae; Thymine Nucleotides | 1986 |
1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
Topics: Animals; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Structure-Activity Relationship | 1986 |
Correlations between necrotic patterns and limb skeletal defects induced by antimitotic drugs in the mouse.
Topics: Abnormalities, Drug-Induced; Animals; Antibiotics, Antineoplastic; Cell Survival; Cytarabine; Cytidine Monophosphate; Ectoderm; Extremities; Female; Glycine; Hyperplasia; Limb Deformities, Congenital; Mesoderm; Mice; Mitosis; Necrosis; Pregnancy; Time Factors | 1983 |
Inability of liposome encapsulated 1-beta-D-arabinofuranosylcytosine nucleotides to overcome drug resistance in L1210 cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cells, Cultured; Cytarabine; Cytidine Monophosphate; DNA, Neoplasm; Drug Resistance; Female; Leukemia L1210; Liposomes; Mice; Mice, Inbred DBA | 1981 |
1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Cell Line; Cells, Cultured; Cytarabine; Cytidine Monophosphate; Cytosine Nucleotides; Humans; Sialic Acids; Sialyltransferases; Transferases | 1980 |
The effects of cytosine arabinoside on RNA-primed DNA synthesis by DNA polymerase alpha-primase.
Topics: Arabinonucleotides; Base Sequence; Cytarabine; Cytidine Monophosphate; DNA Primase; DNA Primers; DNA Replication; Kinetics; Molecular Sequence Data; RNA Nucleotidyltransferases; Templates, Genetic | 1995 |
[Plasma concentration of cytosine arabinoside (Ara-C) in the elderly patients with hematological malignancy treated by Ara-C or cytarabine ocfosfate (SPAC)].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes | 1995 |
[Therapy-related acute non-lymphocytic leukemia (M2) with 7;11 chromosome translocation induced into complete remission by low dose cytosine arabinoside and cytarabine ocfosfate therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Cytarabine; Cytidine Monophosphate; Female; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Remission Induction; Translocation, Genetic | 1994 |
Exonucleases and the incorporation of aranucleotides into DNA.
Topics: Animals; Cattle; Chromatography; Cytarabine; Cytidine Monophosphate; DNA; DNA Polymerase gamma; DNA Repair; DNA Replication; DNA-Directed DNA Polymerase; Electrophoresis, Polyacrylamide Gel; Exodeoxyribonucleases; HL-60 Cells; Humans; Kinetics; Leukemia; Recombinant Proteins; Thymus Gland; Time Factors; Tissue Inhibitor of Metalloproteinases | 1999 |
Cyclopentenyl cytosine increases the phosphorylation and incorporation into dna of arabinofu-ranosyl cytosine in a myeloid leukemic cell-line.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carbon-Nitrogen Ligases; Cytarabine; Cytidine; Cytidine Diphosphate; Cytidine Monophosphate; Deoxycytosine Nucleotides; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Myeloid; Phosphorylation | 2000 |
Mechanisms of glycosylation and sulfation in the Golgi apparatus: evidence for nucleotide sugar/nucleoside monophosphate and nucleotide sulfate/nucleoside monophosphate antiports in the Golgi apparatus membrane.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Animals; Biological Transport; Cytidine Monophosphate; Cytidine Monophosphate N-Acetylneuraminic Acid; Golgi Apparatus; Guanosine Diphosphate Fucose; Guanosine Monophosphate; Nucleoside Diphosphate Sugars; Phosphoadenosine Phosphosulfate; Rats; Sialic Acids | 1984 |
Effect of nucleotides on translocation of sugar nucleotides and adenosine 3'-phosphate 5'-phosphosulfate into Golgi apparatus vesicles.
Topics: Adenine Nucleotides; Animals; Binding, Competitive; Biological Transport; Cytidine Monophosphate; Cytidine Monophosphate N-Acetylneuraminic Acid; Golgi Apparatus; Guanine Nucleotides; Guanosine Diphosphate Fucose; Liver; Nucleoside Diphosphate Sugars; Nucleotides; Phosphoadenosine Phosphosulfate; Rats; Sialic Acids; Structure-Activity Relationship; Uridine Monophosphate | 1984 |